Moelis & Company, a leading global independent investment bank, today announced the appointment of Maarten de Jong as a Managing Director providing financial and strategic advice to healthcare clients in the U.S. and internationally. Mr. de Jong will join the Firm in August and will be based in New York.
Mr. de Jong brings nearly 20 years of experience to Moelis & Company having previously worked at Barclays Capital, and formerly Lehman Brothers, where he was most recently Global Head of Life Sciences. At Barclays, he focused on pharmaceuticals, biotechnology and diagnostics, and developed a portfolio of relationships across the U.S. and Europe.
Rick Leaman, Managing Partner of Moelis & Company, said, “With the continued high level of activity in the healthcare sector, Maarten’s appointment, which enhances our existing global healthcare franchise, makes us well positioned to advise clients on their strategic and financial initiatives.”
Mr. Leaman added, “We will continue to see pharmaceutical companies re-aligning their asset portfolios by separating their non-core businesses while also investing further in the growth of their core businesses. This, together with the maturation of the large biotechnology companies, will continue to drive strategic momentum in the broader Life Sciences arena.”